Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Tidsskriftartikel › Forskning › peer review
Accepteret manuskript, 633 KB, PDF-dokument
Forlagets udgivne version
Rare diseases pose a particular priority setting problem. The UK gives rare diseases special priority in healthcare priority setting. Effectively, the National Health Service is willing to pay much more to gain a quality-adjusted life-year related to a very rare disease than one related to a more common condition. But should rare diseases receive priority in the allocation of scarce healthcare resources? This article develops and evaluates four arguments in favour of such a priority. These pertain to public values, luck egalitarian distributive justice the epistemic difficulties of obtaining knowledge about rare diseases and the incentives created by a higher willingness to pay. The first is at odds with our knowledge regarding popular opinion. The three other arguments may provide a reason to fund rare diseases generously. However, they are either overinclusive because they would also justify funding for many non-rare diseases or underinclusive in the sense of justifying priority for only some rare diseases. The arguments thus fail to provide a justification that tracks rareness as such.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Medical Ethics |
Vol/bind | 48 |
Nummer | 9 |
Sider (fra-til) | 624-628 |
Antal sider | 5 |
ISSN | 0306-6800 |
DOI | |
Status | Udgivet - sep. 2022 |
Begivenhed | Measuring Health: Ethical Perspectives - Aarhus University, Aarhus, Danmark Varighed: 18 jun. 2020 → 18 jun. 2020 |
Konference | Measuring Health: Ethical Perspectives |
---|---|
Lokation | Aarhus University |
Land | Danmark |
By | Aarhus |
Periode | 18/06/2020 → 18/06/2020 |
Se relationer på Aarhus Universitet Citationsformater
Aktivitet: Deltagelse i eller arrangement af en begivenhed - typer › Deltagelse i eller organisering af workshop, seminar eller kursus
ID: 216287999